<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">In 1992, the World Health Assembly (WHA) adopted resolution WHA45.17 on immunization and vaccine quality, urging Member States to introduce routine hepatitis B vaccination. More than 90% of the World Health Organization (WHO)â€™s 194 Member States have done so [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR2">2</xref>]. According to WHO, investment in hepatitis B vaccination could prevent an estimated 4.8 million deaths between 2010 and 2020 in the 73 countries supported by the GAVI Alliance [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Large numbers of adults remain chronically infected with hepatitis B virus and are at risk of developing liver disease. For them, prolonged treatment is needed. Besides treatment, the major remaining challenges are to improve coverage of the birth dose of hepatitis B vaccine and to design good prevention and control strategies for viral hepatitis in LMICs.
</p>
